Shukra Pharmaceuticals has entered into a Term Sheet with Borns Medical Robotics Pte Ltd, Singapore, to establish a strategic joint venture.

This new entity, B&S Robotics Private Limited, will focus on designing, manufacturing, distributing, and servicing AI-enabled surgical robotic systems across India and the Asia-Pacific region.

Shukra will hold a 60% stake, contributing capital, its sales network, and market development capabilities.

Borns will provide its technology platform and manufacturing know-how, holding 40%. This collaboration signifies Shukra's entry into the high-tech medical robotics sector, aiming for progressive localization and potential future listing of the joint venture.

The Term Sheet is non-binding, with definitive agreements yet to be executed.